Toxicology

Calling for submissions for the 2022 volume for the following article types: Original Research, Study Characteristics, Clinical Studies, Systematic Reviews, Reviews, Mini Reviews, Case Series, and Commentaries

Meet the Section Editor

Rakesh Dixit, CEO & President, Bionavigen, LLC

Rakesh Dixit is President & CEO at BIONAVIGEN, LLC, a biopharmaceutical virtual drug development company specializing in drug hunting, advising and consulting for all aspects of drug development, including discovery, preclinical development, CMC, translational sciences, clinical development and regulatory filing. He conducted extensive graduate and post-graduate training in pharmacology, toxicology and biochemistry at both Indian and US institutions (Case Wester Reserve University, Medical College of Ohio and the University of Nebraska) and is a Diplomate and Board Certified in Toxicology from the American Board of Toxicology Inc since 1992. Dixit is an accomplished executive, inventor and scientist with over 30 years of success, working with top biotechnology and pharmaceutical companies. In 2015, Dixit was selected by PharmaVoice as one of the 100 Most Inspiring People in the Pharmaceutical Industry. Dixit was a key contributor to the development and approval of ten blockbuster pharmaceuticals to the market. Currently Editor-in-Chief of Toxicology Mechanisms and Methods, and Associate Editor of Toxicology Applied Pharmacology and the Journal of Toxicology and Environmental Health—Dixit has published more than 80 peer-reviewed papers and delivered over 130 invited lectures, presentations and workshops.